Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$431,794
+$100,677 QoQ
Shares Held
360
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#3,867
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AFFINITY INVESTMENT ADVISORS, LLC holds $11,731,822 across 9 Drug Manufacturers - General names. LLY ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,898 | $2,239,092 | |
| 2 | JNJ |
Johnson & Johnson
|
8,462 | $2,149,094 | |
| 3 | PFE |
Pfizer Inc
|
79,689 | $1,918,911 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
30,557 | $1,760,694 | |
| 5 | AMGN |
Amgen Inc
|
4,328 | $1,567,255 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,172 | $921,602 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
360 | $431,794 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,040 | $384,073 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $431,794 | 360 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $331,117 | 360 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $386,884 | 360 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $274,680 | 360 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $280,630 | 360 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $297,327 | 360 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $277,920 | 360 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $318,938 | 360 | Shares | Sole | 2024-10-28 | |
| No filing history on record for this holder in this stock. | ||||||